Achieve compliance through year-end pharma annual requirements
Bio Pharma Dive
AUGUST 9, 2021
Receive drug conversion and submission services by our expert staff, to remain compliant with the FDA
Compliance Related Topics 
208 
Hidden compliance risks for life sciences companies
Pharma Phorum
MAY 4, 2021
The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
COVID-19: Compliance to household mixing restrictions in England decreased with each lockdown
Scienmag
NOVEMBER 25, 2021
Latest News Compliance COVID19 decreased England household lockdown mixing restrictionsHousehold mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports. The authors observed that the increase in household mixing by mid-February 2021 during the third lockdown coincided with the wider COVID-19 vaccine rollout across England. […].
5 HIPAA Compliance Tips For Healthcare Professionals
Pharma Mirror
JANUARY 3, 2022
They can deal with other healthcare franchises, which also need compliance. There are more reasons why health professionals should have a HIPAA compliance program in their clinics and offices.
Exploring new technology integrations to make research compliance altogether better
Forte Research Systems®
AUGUST 11, 2020
Clinical Research Technologies Compliance and Regulatory Efficient Clinical TrialsSince joining forces a year ago, Advarra and Forte have worked to ensure altogether better research, integrating Advarra’s CIRBI platform and Forte eReg.
FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com
BioTech 365
JULY 4, 2022
FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Quality Management – … Continue reading → Business Wire
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
BioTech 365
JUNE 29, 2022
Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split CHICAGO–(BUSINESS WIRE)–Exicure, Inc.
A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance
Pharma Phorum
FEBRUARY 4, 2021
However, issues like compliance, governance and security often are. These problems tend to be the most severe in the oldest and largest Salesforce orgs, and can result in slow performance, reduced agility, sluggish adoption, misalignment and even compliance and security issues.
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
BioTech 365
MAY 16, 2022
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule VANCOUVER and MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced … Continue reading → GlobeNewswire
Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
BioTech 365
JUNE 29, 2022
Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc.
Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com
BioTech 365
JUNE 28, 2022
Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Sterile Filtration … Continue reading → Business Wire
10th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements is Just Days Away
FDA Law Blog
JUNE 23, 2022
Karst — The American Conference Institute and Council for Responsible Nutrition are hosting the 10th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements live in New York next week, June 29-30. By Kurt R.
MEDIROM Healthcare Technologies Inc. Regains Compliance with Nasdaq Listing Standard
BioTech 365
APRIL 22, 2022
Regains Compliance with Nasdaq Listing Standard MEDIROM Healthcare Technologies Inc. Regains Compliance with Nasdaq Listing Standard NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. MEDIROM Healthcare Technologies Inc. Nasdaq CM: MRM), a holistic healthcare company based … Continue reading → GlobeNewswire
|
Nutra Pharma Provides Business and Compliance Updates
BioTech 365
JULY 26, 2021
Nutra Pharma Provides Business and Compliance Updates Nutra Pharma Provides Business and Compliance Updates Nutra Pharma is providing updates regarding their business plans, accounting and compliance Plantation, Florida, July 26, 2021 (GLOBE NEWSWIRE) — Nutra Pharma Corporation (OTC Pink: NPHC), … Continue reading → GlobeNewswire
Anne Walsh to Moderate FDLI Compliance and Enforcement Panel
FDA Law Blog
DECEMBER 2, 2021
s Anne Walsh will be moderating “Updates in Litigation Risks: Product Liability, Private Litigation, and Consumer Class Actions,” at the upcoming Food and Drug Law Institute’s Enforcement, Litigation, and Compliance Conference on December 9-10. Hyman, Phelps & McNamara, P.C.’s
Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com
BioTech 365
MAY 23, 2022
Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “SOP Writing, Training and Compliance in the Pharmaceutical … Continue reading → Business Wire
Hand Hygiene Compliance Rate During the COVID-19 Pandemic
JAMA Internal Medicine
APRIL 25, 2021
This quality improvement study assesses hand hygiene compliance rates in a hospital with an automated hand hygiene monitoring system during the COVID-19 pandemic
Opentrons Labworks, Inc. Appoints Chief Financial Officer, and Chief Legal and Compliance Officer
BioTech 365
MARCH 15, 2022
Appoints Chief Financial Officer, and Chief Legal and Compliance Officer Opentrons Labworks, Inc. Appoints Chief Financial Officer, and Chief Legal and Compliance Officer LONG ISLAND CITY, N.Y.–(BUSINESS Opentrons Labworks, Inc.
Johnson & Quin Achieves HIPAA Security Compliance Assessment
BioTech 365
NOVEMBER 9, 2020
Johnson & Quin Achieves HIPAA Security Compliance Assessment Johnson & Quin Achieves HIPAA Security Compliance Assessment NILES, Ill.–(BUSINESS –(BUSINESS WIRE)–#colorinkjet—Johnson & Quin, a full-service direct mail production and mailing services company, has successfully achieved the HIPAA Security Compliance Assessment which certifies … Continue reading → Business Wire
Tiziana Life Sciences Ltd. Announces Annual Report Filed to Regain Nasdaq Compliance
BioTech 365
MAY 24, 2022
Announces Annual Report Filed to Regain Nasdaq Compliance Tiziana Life Sciences Ltd. Announces Annual Report Filed to Regain Nasdaq Compliance Form 20-F Filed on May 23, 2022 Following Receipt of Notice from Nasdaq Regarding Filing Deadline … Continue reading → GlobeNewswireTiziana Life Sciences Ltd.
Sharps Compliance Announces Change to Board of Directors
BioTech 365
MAY 24, 2021
Sharps Compliance Announces Change to Board of Directors Sharps Compliance Announces Change to Board of Directors HOUSTON, May 24, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. NASDAQ: SMED) (“Sharps Compliance” or the “Company”), a leading full-service national provider of comprehensive … Continue reading → GlobeNewswire
Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock
BioTech 365
AUGUST 25, 2021
Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock Sharps Compliance Corp. 25, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED), a full service provider of waste management, today … Continue reading → GlobeNewswire
Experts to come together for compliance event ‘validation ready’ global labeling systems
Pharma Phorum
APRIL 28, 2021
Experts to come together for compliance event . This one-hour event is particularly suited to those in industry roles such as compliance, regulatory affairs and quality assurance, or anyone who needs to understand what best practice looks like in a global labeling system.
Politicized pandemic shaped compliance with social distancing
Scienmag
FEBRUARY 24, 2021
Study: Opposing messages, personal beliefs influenced behavior COLUMBUS, Ohio – Politicization of the COVID-19 pandemic had a powerful influence over adherence to social distancing guidelines in the United States and why people did, or did not, comply during the lockdown days, a new study has found. The analysis boiled down to whom study participants trusted […].
Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance
BioTech 365
DECEMBER 14, 2021
Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance CAMBRIDGE, Mass.–(BUSINESS
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
BioTech 365
APRIL 25, 2022
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq BLOOMFIELD HILLS, Mich.–(BUSINESS –(BUSINESS WIRE)–ZIVO Bioscience, Inc. NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development … Continue reading → Business Wire
Sharps Compliance To Present at ROTH Virtual London Conference
BioTech 365
JUNE 16, 2021
Sharps Compliance To Present at ROTH Virtual London Conference Sharps Compliance To Present at ROTH Virtual London Conference HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive … Continue reading → GlobeNewswire
Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
BioTech 365
APRIL 22, 2022
Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Cambridge, MA U.S.A. April 22, 2022) — Allarity Therapeutics, Inc. Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage … Continue reading → GlobeNewswire
Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations
BioTech 365
SEPTEMBER 14, 2021
Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations Simplifi 797 supports the health system’s initiative to … Continue reading → Business Wire
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada
BioTech 365
JUNE 28, 2021
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today … Continue reading → GlobeNewswire
Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee
BioTech 365
APRIL 22, 2021
Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality … Continue reading → Business Wire
Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement
BioTech 365
MARCH 22, 2021
Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a … Continue reading → GlobeNewswire
AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement
BioTech 365
MARCH 5, 2021
AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., AnPac Bio,” the “Company” or “we”) (ANPC), a … Continue reading → GlobeNewswire
Regulatory Compliance Coverage & Reference between FDA 21 CFR Part 11 and EU Annex 11
Cloudbyz
MAY 17, 2022
To ensure continued compliance to these regulations, it is imperative for clinical researchers to understand the similarities and differences between these regulations. Until recently, clinical trials have been performed in a mostly paper-based processes.
Regulatory Compliance Coverage & Reference between FDA 21 CFR Part 11 and EU Annex 11
Cloudbyz
MAY 17, 2022
To ensure continued compliance to these regulations, it is imperative for clinical researchers to understand the similarities and differences between these regulations Until recently, clinical trials have been performed in a mostly paper-based processes.
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
BioTech 365
JANUARY 8, 2021
Regains Compliance with Nasdaq Bid Price Rule Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule MALVERN, Pa., Ocugen Inc. 08, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene … Continue reading → GlobeNewswire
Sharps Compliance Corp. Closes $17.9 Million Underwritten Public Offering of Common Stock
BioTech 365
AUGUST 30, 2021
Sharps Compliance Corp. Million Underwritten Public Offering of Common Stock Sharps Compliance Corp. 30, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Closes $17.9 Closes $17.9 Million Underwritten Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED) (the “Company”) today announced … Continue reading → GlobeNewswire
Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
BioTech 365
DECEMBER 1, 2020
Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement MONMOUTH JUNCTION, N.J., 01, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the … Continue reading → GlobeNewswire
Sharps Compliance Corp. Prices $15.6 Million Underwritten Public Offering of Common Stock
BioTech 365
AUGUST 25, 2021
Sharps Compliance Corp. Million Underwritten Public Offering of Common Stock Sharps Compliance Corp. 25, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Prices $15.6 Prices $15.6 Million Underwritten Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED) (the “Company”) today announced … Continue reading → GlobeNewswire
Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com
BioTech 365
AUGUST 20, 2021
Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “SOP Writing, Training and Compliance in the Pharmaceutical … Continue reading → Business Wire
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
BioTech 365
NOVEMBER 24, 2021
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the … Continue reading → GlobeNewswire
Let's personalize your content